TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma. This evidence concerns the gene NECTIN4 and thyroid gland undifferentiated (anaplastic) carcinoma.